Lucira Health (NASDAQ:LHDX) Trading Down 9.9%
Lucira Health (NASDAQ:LHDX) Trading Down 9.9%
Lucira Health, Inc. (NASDAQ:LHDX – Get Rating)'s share price dropped 9.9% during trading on Tuesday . The company traded as low as $0.20 and last traded at $0.23. Approximately 525,450 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 29,320,967 shares. The stock had previously closed at $0.25.
盧西拉健康公司(NASDAQ:LHDX-獲取評級)的股價在周二交易期間下降了 9.9%。該公司的交易價格低至 0.20 美元,最後交易價格為 0.23 美元。在日間交易期間交易了約 525,450 股,較每日平均成交量 29,320,967 股下跌 98%。該股票以前已收盤 0.25 美元。
Lucira Health Stock Up 5.2 %
盧西拉健康股票上升 5.2%
The company has a debt-to-equity ratio of 0.48, a current ratio of 1.46 and a quick ratio of 0.79. The business has a 50 day moving average price of $0.33 and a 200 day moving average price of $0.58. The firm has a market capitalization of $9.75 million, a P/E ratio of -0.07 and a beta of 3.75.
該公司的債務與權益比率為 0.48,流動比率為 1.46,快速比率為 0.79。該業務的 50 天移動平均價為 0.33 美元,200 日移動平均價格為 0.58 美元。該公司的市值為 975 萬美元,市盈率為 -0.07,貝塔值為 3.75。
Hedge Funds Weigh In On Lucira Health
對沖基金在健康方面的權衡
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Prudential Financial Inc. bought a new position in Lucira Health during the second quarter valued at about $32,000. Renaissance Technologies LLC bought a new position in Lucira Health during the second quarter valued at about $78,000. BlackRock Inc. increased its stake in Lucira Health by 18.8% during the first quarter. BlackRock Inc. now owns 51,468 shares of the company's stock valued at $183,000 after acquiring an additional 8,131 shares during the period. AlphaCentric Advisors LLC bought a new position in Lucira Health during the third quarter valued at about $339,000. Finally, Vanguard Group Inc. increased its stake in Lucira Health by 23.4% during the first quarter. Vanguard Group Inc. now owns 631,767 shares of the company's stock valued at $2,256,000 after acquiring an additional 119,929 shares during the period. 57.02% of the stock is currently owned by institutional investors.
機構投資者和對沖基金最近增加或減少了他們在公司的股份。英國保誠金融股份有限公司於第二季度買入 Lucira Health 的新倉位,價值約為 32,000 美元。文藝復興技術有限責任公司在盧西拉健康第二季度買了一個新的位置,價值約為 78,000$。貝萊德公司在第一季度將其在盧西拉健康的股份增加了 18.8%。在期內額外收購 8,131 股股份後,貝萊德公司現在擁有該公司 51,468 股股份,價值 183,000 美元。Alphacentric 顧問有限責任公司在第三季度購買了盧西拉健康的新頭寸,價值約為 339,000 美元。最後,先鋒集團有限公司在第一季度將其在 Lucira 健康的股份增加了 23.4%。領航集團股份有限公司在期內額外購入 119,929 股股份後,現擁有該公司股票 631,767 股,價值 2,256,000 美元。目前,該股票的 57.02% 由機構投資者擁有。
Lucira Health Company Profile
盧西拉健康公司簡介
(Get Rating)
(取得評分)
Lucira Health, Inc, a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits.
Lucira Health, Inc 是一家醫療技術公司,專注於傳染病檢 test 劑盒的開發和商業化。它開發了一個生產分子測試服務的測試平台。該公司提供 LUCIRA COVID-19 一體化檢測套件,一套 COVID-19 test 套件;並開發出甲型和乙型流感病毒 test 套件。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Lucira Health (LHDX)
- The Squeeze Is On For EVGo, Rally To Follow
- Is The Bottom In For RH, Or Is This Just A Stopping Point?
- Dividend King H.B. Fuller Signals Slowing In 2023
- Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
- 3 Companies That Just Started Paying Dividends
- 免費獲取有關露西拉健康(LHDX)的研究報告
- eVGo 的擠壓正在進行,集會跟隨
- 是 RH 的底部,還是這只是一個停止點?
- 股息國王 H.B 富勒信號在 2023 年放緩
- SoFi 技術在銀行危機中是否可以購買?
- 3 家剛開始支付股息的公司
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收盧西拉健康日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Lucira Health 及相關公司的最新新聞和分析師評級的簡明每日摘要。